Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)
Introduction and Objectives: Non-invasive tests (NITs) identifying high-risk MASLD in primary care is suggested but, these strategies cost-effectiveness remain uncertain in the United Kingdom (UK). Materials and Methods: A cost-utility/budget impact model was developed for cost-effectiveness evaluat...
Saved in:
| Main Authors: | Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Annals of Hepatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268125000134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D Instruments
by: Zobair M. Younossi, et al.
Published: (2025-01-01) -
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD
by: Julia Frączek, et al.
Published: (2025-04-01) -
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in India
by: Debasis Datta, et al.
Published: (2025-07-01) -
Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank
by: Qi Feng, et al.
Published: (2025-07-01) -
Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography
by: Rajat Deb, et al.
Published: (2025-03-01)